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Transmitochondrial cytoplasmic hybridAutophagy is a cellular housekeeping process that removes damaged or unwanted cellular components and
recycles them to build new constituents. It is essential for tumor growth under adverse environment.
Mitochondria play an important role in the formation of autophagosome and its subsequent docking and
fusion with lysosome. To understand the contribution of mitochondria to the regulation of homeostatic
autophagy in cancer cells, we used the transmitochondrial cytoplasmic hybrid (cybrid) model. Cybrid system
allowed us to compare mitochondria from different cell types including highly metastatic breast cancer cell
line MDA-MB-231 (c231), less metastatic breast cancer cell lines: MDA-MB-436 (c436) and MDA-MB-468
(c468), as well as non-cancerous mammary epithelial cell MCF-10A (c10A) in a deﬁned nuclear background.
The c231 exhibited lower LC3-II levels but higher ratio of LC3-II/LC3-I than c436, c468 and c10A. In addition,
c231 displayed more punctate LC3-positive cells and had lower levels of sequestosome 1 (p62/SQSTM1) than
other cybrids. These suggested that mitochondria could contribute to the increased autophagy and autophagic
ﬂux in metastatic cancer. This increased autophagy was found to be non-selective autophagy instead of
selective mitophagy since LC3 puncta in c231 did not co-localize with mitochondria labeled by Mitotracker
red or Tomm 20. The promotion of mitochondrial permeability transition (MPT) in c231 also contributed
to increased autophagy. Block of MPT by the inhibition of low-conductance stage of MPT pores resulted in
a decrease of LC3 puncta in c231. These results suggested that mitochondria from highly metastatic
breast cancer cell line MDA-MB-231 can promote homeostatic autophagy of cancer through opening low-
conductance MPT pores.H grant CA10023, Department
ant W81XWH-04-1-0650, and
from Taiwan National Science
016-MY2).
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Autophagy is a dynamic catabolic process in which cellular proteins,
organelles, and cytoplasmic constituents are degraded and recycled to
sustain cellmetabolism [1,2]. At theﬁrst step of autophagy, the isolation
membrane, an intracellular lipid bilayer structure is developed under a
positive control of the class III phosphatidylinositol 3-kinase (PI3K)/
beclin 1 protein complex [3]. This isolationmembrane then elongates its
length, sequesters cytoplasmic components, and ﬁnally forms a vesicle
called the “autophagosomes”. During this process, LC3 (microtubule
associated protein 1 light chain 3) is cleaved into a soluble form known
as LC3-I and further modiﬁed into a membrane-bound form, LC3-II,
which is recruited onto the autophagosomes [4]. Subsequently, thefusion of autophagosomes with lysosomes results in the formation of
autolysosomes in which acid hydrolases ultimately degrade the
enclosed material [3]. Constitutive autophagy acting in parallel with
ubiquitin proteasome system serves to eliminate toxic proteins,
damaged organelles or pathogens and maintain the cellular homeosta-
sis. Once cells encountered a metabolic stress or energy crisis, they
utilize autophagy to sustain their temporary survival, as it provides an
alternative energy sources, until death [5]. Therefore, autophagy can
protect cells against shortage of nutrients as a prosurvival mechanism
[6].
At the early stage of tumor development, autophagy functions as
a tumor suppressor. This is evidencedby theobservation that autophagy
defects due to allelic loss of beclin are common in human ovarian, breast
and prostate tumors [7–10]. The loss of essential role of autophagy
causes the accumulation of cellular defects, suggesting a loss of function
tumor suppressor mechanism of autophagy in the removal and
recycling of damaged cellular components [11]. Paradoxically, activa-
tion of autophagy may serve as a survival mechanism against stressful
conditions such as hypoxia and nutrient deprivation in the poorly
vascularized central areas of a solid tumor [5]. For example, autophagy
is found to be activated in pancreatic and colorectal cancer [4,12].
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colorectal cancer [4]. In other cases, RNA interference of autophagy
related proteins enhanced tamoxifen-induced apoptosis in tamoxifen-
resistant breast cancer cell lines [13]. These ﬁndings suggest that
autophagy may contribute to promotion of tumor progression by
enhancing oncogenic properties. However, how autophagy is paradox-
ically regulated in cancer cells during multisteps of tumorigenesis is
remained to be determined.
Mitochondria are key players in several cellular functions including
growth, division, energy metabolism, and apoptosis. Obviously,
these functions are crucial for cancer cell proliferation, survival, and
metastasis. Reprogramming of energy metabolism by switching from
mitochondrial oxidative phosphorylation to glycolysis is a hallmark of
cancer [14,15]. Mitochondrial respiratory functions are reduced in
cancer cells [16]. In some reports, reduced mitochondrial energy
metabolism was supported by the ﬁnding of deleterious mitochondrial
DNA mutations in tumors [16–18]. In our previous studies using
transmitochondrial cytoplasmic hybrids (cybrids) systems in a deﬁned
nuclear background, mitochondria derived from various breast cancer
cell lines (MDA-MB-231, MDA-MB-436 or MDA-MB-453 had been
shown to confer signiﬁcant reduction in mitochondrial functions
including electron transport chain activities, oxygen consumption, and
ATP synthesis rates [16]. This observation led us to hypothesize that
mitochondria derived from breast cancer cells may contribute to
autophagic activities in cancer. To test this hypothesis, cybrids from a
normalmammary epithelial cell line, MCF-10A, and three breast cancer
cell lines (MDA-MB-231, MDA-MB-436, and MDA-MB-468) with
different tumorigenic and metastatic properties have been developed
to test the effect of cancer mitochondria on autophagic activities.
2. Materials and methods
2.1. Cell culture
The osteosarcoma-derived cell line 143B.TK− (143B), the mam-
mary epithelial cell line MCF-10A, and breast cancer cell lines; MDA-
MB-231, MDA-MB-436 and MDA-MB-468, were obtained from the
American Type Culture Collection (Manassas, VA). The metastatic and
tumorigenic properties of these cell lines are listed in Table 1 [19–22].
MCF-10A cells were cultured in DMEM/F12 (Invitrogen), and other
cell lines were maintained in DMEMmedium supplemented with 10%
fetal bovine serum (FBS), 2 mM L-glutamine, 100 U/ml penicillin,
100 μg/ml streptomycin, and 0.1 mg/ml bromodeoxyuridine in a
humidiﬁed incubator at 37 °C with 5% CO2. Serum starvation was
performed by treating 2×105 cells per well in six-well plates with
Hank's Balanced Salt Solution (HyClone, Logan, UT, USA) for 2 h. In
balﬁlomycin A1 (Baf-A1; Sigma) experiments, cells were treated with
100 nM Baf-A1 for 18 h.
2.2. Generation of cybrids
Rho0 (ρ0) cells depleted ofmitochondrial DNAwere generated from
143B cells by repetitive treatment with ethidium bromide [16]. Cybrid
cellswere constructed by fusionof enucleatedmitochondrial donor cells
with ρ0 cells as described previously [16]. The absence of nuclear DNA
from the original donor cells in the cybrids was conﬁrmed by DNATable 1
Metastatic and tumorigenic properties of cell lines used.
Tumorigenic property Metastatic potency Reference
MCF-10A Non-tumorigenic Non-metastatic [19]
MDA-MB-231 Tumorigenic Highly metastatic [20–22]
MDA-MB-436 Non-tumorigenic Moderately metastatic [20–22]
MDA-MB-468 Tumorigenic Non-metastatic [20,22]sequencing of the p53 gene, which harbors speciﬁc mutations or
variants in the original breast cancer cell lines. The cybrids generated
containing mitochondria derived from MCF-10A, MDA-MB-231, MDA-
MB-436 and MDA-MB-468 cells are named as c10A, c231, c436 and
c468, respectively.
2.3. Western blot analysis
Cells were lysed in RIPA buffer, and proteins were analyzed by
Western blot with the antibodies used were: anti-LC3B (1:1000, Cell
Signaling), anti-beclin 1 (1:1000, Cell Signaling), anti-p62/SQSTM1
(1:2000, Sigma), and anti-actin (1:3000). The membranes were
incubated with horseradish peroxidase-conjugated anti-mouse or
anti-rabbit IgG (1:3000) secondary antibody (Cell Signaling). Protein
bands were visualized by ECL Western blotting detection system
(GE Healthcare). Densitometric semi-quantiﬁcation was performed
using QuantityOne software (BioRad).
2.4. Reverse transcription and quantitative real-time PCR
Total RNA isolation (Invitrogen) and cDNA synthesis (Superscript
III RT-PCR kit, Invitrogen) were performed according to manufac-
turer's protocols. Quantitative real-time PCR was performed in
triplicate and normalized to the housekeeping gene, D-glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH), using SybrGreen re-
agent (Bio-Rad) and ABI-Prism 7900HT sequence detection system
(Applied Biosystems, Carlsbad, CA USA). Primer sequences were: LC-3
forward primer— 5′GATGTCCGACTTATTCGAGAGC3′ and LC-3 reverse
primer — 5′TTGAGCTGTAAGCGCCTTCTA3′; GAPDH forward primer —
5′AGCCACATCGCTCAGACACCA3′ and GAPDH reverse primer — 5′
GCAAATGAGCCCCAGCCTTC3′.
2.5. Distribution of GFP-LC3
The green ﬂuorescent protein-tagged LC3 (GFP-LC3) expressed
cybrids were generated by transfection with the GFP-LC3 expression
plasmid, kindly provided by our colleague, Dr. Eissa [23]. Forﬂuorescence
imaging, cells were ﬁxed with 4% paraformaldehyde, stained with 4′-6-
diamidino-2-phenylindole dihydrochloride (DAPI) andmounted using a
SlowFade Antifade Kit (Invitrogen). Images were acquired on a Nikon
Eclipse 90I ﬂuorescence microscope (Tokyo, Japan). Digitally captured
images were processed and analyzed using Imaging Software NIS-
Elements (Nikon, Japan). To quantify the percentage of autophagic cells,
at least one hundred cells were randomly counted. Those containing
more than ﬁve green puncta were considered autophagic (punctate
LC3-positive cells) [24].
2.6. Immunoﬂuorescence staining
Cells were ﬁxed with 4% paraformaldehyde, permeabilized with
ice cold 0.3% Triton X-100, and blocked with 10% normal goat serum.
After washing, cells were probed with primary antibodies, anti-LC3B
(1:200), and anti-Tomm20 (1:100, Abnova), in PBS/0.1% Triton X-100
at 4 °C overnight, followed by incubation with adequate Alexa Fluor
anti-IgG (Invitrogen) secondary antibodies. Whenmitochondria were
probed with Mitotracker red, cells are loaded with 200 nM Mito-
tracker red for 15 min in the incubator before ﬁxation. DAPI (1 μM)
were used for counterstaining of nuclei. Images were acquired as
described above.
2.7. Determination of ROS production
The cells were seeded and grown in 24-well plates (2×104 perwell)
for 24 h. ROS production was measured after loading with 5 μmol/L
dichlorodihydroﬂuorescein diacetate (Invitrogen,Molecular Probes) for
30 min. After washing with PBS, cells were incubated in the medium
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emission wavelengths of 485 and 535 nm, respectively) were carried
out with a Tecan Inﬁnite M200 multimode microplate reader
(Mannedorf, Switzerland).
2.8. Measurement of mitochondria permeability transition
Cells at 2×105/ml were grown in six-well plates overnight. The
opening of mitochondria permeability transition (MPT) pore was
detected by image-iT™ live mitochondrial transition pore assay kit
(Invitrogen). Brieﬂy, cellswere pre-incubated in a cocktail of calcein AM
(1 μM), CoCl2 (1 mM), MitoTracker Red (200 nM), and DAPI (1 μM) for
15 min at 37 °C. Afterwashingwithmedium, living cellswere visualized
by inverted ﬂuorescence microscope as previously mentioned. When
MPT pore is open, cytosolic cobalt can freely enter mitochondria and
subsequently quenches the green ﬂuorescence of calcein in mitochon-
dria. Thus,mitochondriawith increased permeability transition showed
only red ﬂuorescence instead of colocalization of red and green in
normal mitochondria. To quantify the percentage of MPTP-open cells,
one hundred cells were randomly counted in ﬁve independent
experiments. In order to block MPTP, cells were treated with 0.2 μM
cyclosporine-A for 1 h before harvest.
2.9. Statistical analysis
Data were expressed as means±S.D. Statistical analysis was
performed by using Student's t-test (two-tailed). The criterion for
statistical signiﬁcance was taken as pb0.05.
3. Results
The characterization of mitochondrial function in mitochondrial
DNA depleted ρ0 cells from 143B cell line and cybrids, c10A, c231, andFig. 1. Autophagy in cybrids. Cybrids were incubated in the presence (basal stage) or abse
becline 1 antibodies. Representative pictures of protein expression of beclin 1 and LC3 at bas
medium (B) were shown. Densitometry quantiﬁcation of LC3-I and LC3-II after normalization
represents the fold change compared to c10A (*pb0.05, #pb0.01, Data are means±SD).c436 with mitochondria derived from MCF10A, MDA-MB-231, and
MDA-MB-436, respectively, has recently been published [16]. In this
study, we have also included c468 with mitochondria derived from
MDA-MB-468 breast cancer cells [unpublished data]. In brief, the ATP
synthesis rates, oxygen consumption, and most mitochondria respi-
ratory chain complex activities were signiﬁcantly reduced in c231,
c436 and c468 compared to c10A ([16], unpublished data). The origins
of the nucleus and themitochondria of these cybrids had been veriﬁed
by DNA sequencing of the respective genome from the parental cell
lines and the cybrids ([16], unpublished data). These characterized
cybrids are used for all the autophagy studies described here.3.1. Cybrid with mitochondria derived from the highly metastatic breast
cancer cell line exhibit increased autophagic activities compared to cybrids
with mitochondria derived from less metastatic and non-cancerous
cell lines
Conversion of the cytoplasmic form of LC3 (LC3-I) to the
autophagosomal membrane-bound form of LC3 (LC3-II) is a speciﬁc
marker for autophagy [23]. The c231 exhibited lower amounts of both
the LC3-I and LC3-II at basal stage, when compared to c10A, c436, and
c468 (Fig. 1A). Though the fraction of LC3-II increased in all cybrids
after serum starvation, c231 persisted to have the lowest LC3-I and
LC3-II expressions (Fig. 1B). The ratio of LC3-II to LC3-I is another
index of autophagy [25]. Although the absolute amount of LC3-II
was the lowest in c231, the ratio of LC3-II to LC3-I was the highest
in c231 compared to other cybrids (Fig. 1C and D). These results
suggested that mitochondria derived from the highly metastatic
cell line altered the autophagy status in the cybrid. Another autophagy
associated protein, beclin 1 showed comparable expression among the
different cybrids in normal growth medium (Fig. 1A) but slightly
increased for cybrids containing cancer mitochondria in starvation
medium (Fig. 1B).nce (serum starvation) of serum for 2 h, harvested and immunoblotted with LC3 and
al stage (A) and at 2 h after serum starvation with Hank's Balanced Salt Solution (HBSS)
to β-actin (C) and the ratio of LC3-II/LC3-I (D) at basal stage (n=7) was present. Y axis
Fig. 2. Image evidence of autophagy in cybrids. For evaluation of endogenous LC3, all cybrids were ﬁxed, stained with DAPI and immuno-labeled with LC3 antibody followed by Alex
Fluor 488-conjugated goat anti-rabbit IgG. GFP-LC3 expressed cybrids were established by transfection with GFP-LC3 expression plasmid. Representative images of endogenous LC3
(A, scale bars=10 μm) and GFP-LC3 (C, scale bar=100 μm) in cybrids at basal stage were shown as well as their quantiﬁcation of punctate LC3-positive cells from endogenous LC3
(B) and GFP-LC3 (D). Values were obtained from ﬁve independent experiments. (*pb0.05, #pb0.01, Data are means±SD).
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numbers of LC3 puncta [24]. As expected, c231 showed increased
number of endogenous punctate LC3-positive cells (Fig. 2A and B).
Similar results were also observed in GFP-LC3 transfected cybrids
(Fig. 2C and D).Fig. 3. Autophagic ﬂux. A. Quantitative real-time PCR analyses of LC3mRNA expression in the
used tomeasure the levels of p62/SQSTM1 in all cybrids at basal stage. Representative picture
Y axis represents the fold change compared to c10A. (*pb0.05, #pb0.01, data aremeans±SD
harvest. Cell lysates were analyzed by immunoblotting for p62/SQSTM1 and LC3.3.2. Cybrid with mitochondria derived from MDA-MB-231 showed
increased autophagic ﬂux
The reduction of LC3-I and LC3-II expression in c231may be due to a
reduction of protein production or an increase of protein degradation.cybrids at basal stage were shown (n=4, data aremeans±SD). B. Immunoblotting was
s were on upper panel. Densitometric quantiﬁcation was shown on lower panel (n=5).
). C. Cybrids were incubated with 0.1% DMSO or 100 nM Balﬁlomycin-A1 for 18 h before
Fig. 4. ROS and MPT in cybrids. A. The amount of ROS was measured in all cybrids by
ﬂuorescence changes due to intracellular oxidation of dichlorodihydrogluorescein
diacetate (n=4). B. Representative pictures of cybrids stained with cocktails of calcein
(green), MitoTracker Red (red), CoCl2 and DAPI (blue) were shown. Arrows indicated
cybrid cells with open mitochondrial permeability transition (MPT) pore, which
expressed the red ﬂuorescence (Scale bars=50 μm). C. The percentages of MPT pore-
open cells in all cybrids were quantiﬁed per 100 cells in each independent experiments
(n=5). *pb0.05, #pb0.01, data are means±SD.
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in c231 (Fig. 3A). This suggests that decreased LC3 protein production
due to decreased mRNA may not be the major cause of reduction in
LC3 protein. LC3 protein can be rapidly degraded in autolysosomes in
late stage of autophagy. A simultaneous decrease in LC3-I and LC3-II
could indicate a fast autophagic ﬂux and a high turnover rate of LC3-II
[25]. One of the markers for autophagic ﬂux is sequestosome 1
(p62/SQSTM1), which serves as a link between LC3 and ubiquitinated
substrates and is degraded in autolysosomes. The p62/SQSTM1 level
decreases when the autophagic ﬂux increases [25]. We thus analyzed
the expression of p62/SQSTM1 in all cybrids. As shown in Fig. 3B, the
expression of p62/SQSTM1 was the lowest in c231 and appeared to
correlate with the metastatic potential of the mitochondria donor
cells. These observations, together with the results from Figs. 1 and 2
suggested that mitochondria derived from tumorigenic and highly
metastatic cells exhibited increased autophagic ﬂux in the cybrid
compared tomitochondria derived from lessmetastatic ornon-cancerous
breast cancer cell line.
To verify that the decrease of LC3 in c231 was a result of protein
degradation, LC3 protein levels were investigated in the presence of
Baf-A1, an inhibitor of autolysosome formation [26]. As showed in
Fig. 3C, Baf-A1 inhibited the degradation of LC3-II and p62/SQSTM1 in
c231.
3.3. Linkage of tumor mitochondria and autophagy
The reactive oxygen species (ROS) and opening of mitochondrial
permeability transition (MPT) pores had been reported to induce
autophagy [27]. Fig. 4A showed that the ROS production at basal stage
is lowest in c436 and highest in c468, suggesting that ROS may not be
responsible for the increased autophagy in c231. Interestingly, c231
had signiﬁcantly higher amount of MPT pore-open cells than other
cybrids (Fig. 4B and C). To investigate the causal relationship between
MPT pore opening and autophagy, the cybrids were treated with
cyclosporine-A to block the mitochondrial permeability transition
[27]. Punctate LC3-positive cells were signiﬁcantly decreased with
most notably in c231 (Fig. 5A and B). The expression of LC3-II in c231
also decreased after treating with cyclosporine-A (Fig. 5C). It indicates
that tumor mitochondria could activate autophagy by increasing
mitochondria permeability transition.
In general, autophagy refers to a non-selective process that involves
the degradation of cytosolic components [28,29]. However, there are
instances in which organelles, such as mitochondria appear to be
preferentially sequestered for degradation knownasmitophagy [30]. To
understand whether the activated autophagy in c231 is due to
mitophagy or non-selective autophagy, double staining immunoﬂuo-
rescence analysis was performed using mitochondrial membrane
potential-sensitive dye Mitotracker red or antibody against mitochon-
drial outer membrane protein, Tomm20 with LC3. As shown in Fig. 6,
mitochondria labeled by Mitotracker red (Fig. 6A–D) or Tomm20
(Fig. 6E–G) did not co-localize with autophagosomes marked as green
LC3 puncta structures. These results suggest that increased autophagic
ﬂux in the cybrid caused by tumor mitochondria is not a mitochond-
rially-derivedmitophagic process, but rather, a non-selective formation
of autophagosomes.
4. Discussion
Autophagy occurs at basal level in most tissues in order to
maintain cellular homeostasis [29]. Different cells exhibit different
autophagic behavior and autophagy may be altered by different
culturing conditions. These differences make the comparison of the
autophagy process in different cell lines difﬁcult. Mitochondria, the
power house of the cell, play a central role in cell survival and death,
and are essential to several cellular processes, including energy
metabolism and apoptosis. In recent years, mitochondria werereported to regulate autophagy and may serve as a switch between
apoptosis and autophagy [28,31]. To fully investigate the role of
mitochondria in the regulation of cellular autophagy, the inﬂuence of
the nuclear background must be excluded. The utility of the
transmitochondrial cytoplasmic hybrid system allows the study of
the effect of cancerous mitochondria on autophagy in a common
nuclear background and identical culturing conditions [16,32]. This
study has demonstrated that mitochondria derived from MDA-MB-
231 cells exhibited accelerated autophagic ﬂux in the cybrid, resulting
in decreased levels of LC3-II and p62/SQSTM1 in the absence of
exogenous stimuli, such as starvation. It also increased late-stage
autolysosome formation, when compared to mitochondria derived
from normal mammary epithelial cell line (MCF-10A) and other non-
tumorigenic, MDA-MB-436, or non-metastatic, MDA-MB-468 breast
cancer cell lines. MDA-MB-231 is a highlymetastatic breast cancer cell
line, while MDA-MB-436 and MDA-MB-468 are not [20–22]. These
Fig. 5. Inhibition on MPT pores in the cybrids. The cybrids were incubated with vehicle (DMSO) or 0.2 μM cyclosporine-A for 1 h before harvesting for immunoﬂuorescence and
immunoblotting of LC3. A. Representative immunoﬂuorescence pictures of LC3 (green) and DAPI (blue) in each cybrid (scale bar=50 μm) were shown. B. The percentages of LC3
punctate-positive cells were calculated per 100 cells in each independent experiments (n=6, *pb0.05, #pb0.01, means±SD). C. Representative immunoblotting images of LC3
were shown.
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MDA-MB-231 with highly metastatic potency can up-regulate the
baseline autophagic activities. The ability of tumor mitochondria to
increase autophagymay help cancer cells to fulﬁll high anabolic needs
during rapid growth. Additionally, it also may promote cancer cells to
survive under stressful cancerous environments.
While apoptosis is type I programmed cell death, autophagy is
regarded as type II programmed cell death [28]. Thus, some anti-cancer
therapies have been developed to target on manipulating autophagy
[28]. However, whether autophagy is pro-survival or pro-death in
response to anti-cancer therapeutics remains controversial [5,28]. It has
been shown that inhibition of autophagy at different stages of tumor
development yields different results [5]. For example, inhibition of early
stage of autophagy by 3-methyladenine rescued cancer cells from cell
death inmalignant glioma cell types treatedwith temozolomide [33]. In
contrast, inhibition of late stage of autophagy by Baf-A1 in the same
study induced apoptotic death. Inhibition of autophagy-related genes
sensitized MDA-MB-231 cells to ionizing radiation, and Baf-A1
signiﬁcantly decreased survival of MCF-7 after irradiation [34]. Our
results demonstrated that mitochondria derived from MDA-MB-231
cells could induce autolysosomes, the characteristic of late stage of
autophagy, without changing the early autophagy marker, beclin 1.
Thus, inhibitors targeting late stage autophagy might be considered in
combinationwith other anti-cancer therapies in treating breast cancers
with metastasis. Further studies are necessary to investigate its clinical
application.
Increase of MPT, loss of mitochondria membrane potential and
accumulation of mitochondrial ROS could potentially activate both
apoptosis and autophagy [3,31]. In our study, tumor mitochondria
derived from MDA-MB-231 do not increase the ROS production in the
cybrid. Instead, it increases MPT to induce non-selective autophagy.
Thus, tumormitochondria might induce autophagy by the regulation ofits ownmitochondria permeability without complete loss of mitochon-
driamembranepotential and the release ofmitochondriaROS. There are
two kinds of conductance states of MPT pores to regulate mitochondria
permeability transition: low and high [35]. The high-conductance state
of MPT pores causes the inner mitochondrial membrane permeable to
solutes of up to 1500 Da and therefore leads to the release of factors
from the intermembrane space of mitochondria. Most of the released
factors, such as cytochrome c, ROS or apoptosis inducing factors, are
capable of inducing apoptosis. The high-conductance state ofMPT pores
additionally causes depolarization of mitochondria, which is known to
inducemitophagy [27]. On the other hand, the low-conductance state of
MPT pores allows passage of only small ions across the inner
mitochondrial membrane. It is thought that the passage of small ions
does not induce cell death but aids in the ﬁne regulation of cell
metabolism [36,37]. Since autophagy has the similar role in the
regulation of cell metabolism, low-conductance state of MPT pores
may cross-talk with autophagy. This is supported by our ﬁndings that
the activation of autophagy by tumor mitochondria fromMDA-MB-231
was reduced by cyclosporine-A, which is the inhibitor to block the low-
conductance state of MPT pores. Furthermore, the increased autophagic
ﬂux induced by cancer mitochondria observed in this study is a non-
selective autophagic process instead of a selective mitophagy.
Our study using transmitochondrial cytoplasmic hybrid system
provides evidence that tumor mitochondria may promote mitochon-
dria permeability transition through opening the low-conductance
MPT pore to affect baseline non-selective autophagy. Further studies
are needed to clarify what small factors are released from low-
conductance MPT pores to regulate the non-selective autophagy. Use
of other cybrids derived from different metastatic cell lines and
investigation of in vivo nude mice xenograft are also necessary to
directly link autophagic activities of mitochondria with anti-apoptotic
and metastatic properties.
Fig. 6. Non-selective autophagy. A–D. Cells of c231 were incubated with Mitotracker red (red) for 15 min, ﬁxed, and stained with LC3 antibody followed by Alex Fluor 488-
conjugated goat anti-rabbit IgG (green). Representative immunoﬂuorescence pictures of mitochondria (Mitotracker red, A), autophagosomes (LC3, B) and overlap (C) were shown.
An enlarged image of overlap (D) displayed non-co-localization of mitochondria with autophagosomes. E–G. Cells of c231 were ﬁxed and doubly immunostained with LC3 (Green)
and Tomm20 (red) antibodies. Representative immunoﬂuorescence images of Tomm20 (E), LC3 (F) and their overlap (G) were presented. Scale bar=10 μm.
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